
Vidplack 50mg Tablet
Marketer
Placker Life Sciences
Salt Composition
Vildagliptin (50mg)
Overview Vidplack 50mg Tablet
Diabetac 50mg tablets are indicated for the management of type 2 diabetes. Optimal blood glucose control is achieved through its use in conjunction with a balanced diet and regular physical activity, thereby mitigating the risk of severe diabetic complications, such as renal impairment and vision loss. Diabetac 50mg tablets are typically prescribed when dietary and exercise modifications, or other medications, fail to adequately regulate blood sugar. It may be administered alone or in combination with other antidiabetic agents. This medication can be taken with or without food. Dosage is individualized based on the patient's health status and glycemic control. Adherence to the prescribed regimen, as directed by a physician, is crucial. Consistent daily dosing at the same time maximizes therapeutic benefit. Discontinuation should only occur under medical supervision. Continued adherence to the recommended diet and exercise plan remains essential during treatment. Lifestyle factors significantly influence diabetes management. Common adverse events associated with Diabetac 50mg tablets include hypoglycemia, tremors, headache, vertigo, weariness, and nausea. Recognizing hypoglycemic symptoms (lightheadedness, sweating, dizziness, syncope, and xerostomia) and appropriate management strategies (e.g., glucose tablets) are vital. Persistent or concerning side effects warrant medical consultation. Prior to initiating treatment, patients with a history of renal dysfunction, cardiovascular disease, or pancreatic disorders should inform their physician. Similarly, pregnant or lactating individuals require medical guidance. Potential drug interactions necessitate disclosure of all concurrent medications. Alcohol consumption should be moderated due to the heightened risk of hypoglycemia. Regular monitoring, including renal function and blood glucose levels, ensures optimal therapeutic efficacy.
Primary Ingredients of Vidplack 50mg Tablet
No text provided to rephrase.
Uses of Vidplack 50mg Tablet
Managing Type 2 diabetes
Major Benefits of Vidplack 50mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 50mg Vidplack tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, however, consistent timing is recommended.
Common Side effects of Vidplack 50mg Tablet:
- Hypoglycemia (low blood glucose level)
- Tremors
- Headache
- Dizziness
- Fatigue
- Nausea
How to use Vidplack 50mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vidplack 50mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Vidplack 50mg Tablet works:
Glycemia 50mg tablets are used to manage diabetes. Their mechanism involves stimulating pancreatic insulin secretion while simultaneously suppressing hyperglycemic hormones. This action lowers both fasting and postprandial glucose concentrations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vidplack 50mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Vidplack 50mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against potential risks prior to prescription. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Vidplack 50mg tablets are likely incompatible. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Vidplack 50mg Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Vidplack 50mg Tablets is generally considered safe for individuals with kidney disease, and dosage modification is typically unnecessary. Nevertheless, patients experiencing moderate to severe kidney impairment may necessitate a dosage alteration. Physician consultation is advised.
LiverUNSAFE
The use of Vidplack 50mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Vidplack 50mg Tablet :
Should you forget a Vidplack 50mg Tablet dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Vidplack 50mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinecarbonitrile derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
| Behavioral Class | Dipeptidyl peptidase-4 inhibitors |
